Image_5_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

Image_2_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

Image_3_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

ALDH2 inhibitors decrease stroma-induced ALDH activity in AML cells and sensitize them to chemotherapy. by Bin Yuan (19897)

Table_1_GABARAPL1 Promotes AR+ Prostate Cancer Growth by Increasing FL-AR/AR-V Transcription Activity and Nuclear Translocation.DOCX by Bing Su (51332)

“…However, the therapies are not curative due to diverse range of resistance mechanisms. …”

Table_1_An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae.docx by Jutamas Shaughnessy (166043)

“…<p>Novel therapeutics against the global threat of multidrug-resistant Neisseria gonorrhoeae are urgently needed. …”

Supplementary Figures from Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors by Damir Varešlija (7954046)

“…Figure S3: pSer118 ER expression significantly increases during neoadjuvant AI therapy. Figure S4: Androgen Receptor (AR) expression in patient tumours before and after endocrine therapy. …”

DataSheet_2_IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer.docx by Nicholas R. Hum (12563075)

DataSheet_1_IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer.pdf by Nicholas R. Hum (12563075)

Afatinib decreases MAPK and AKT activation after MET knockdown. by Karolin Ebert (7434713)

Network resistance. by Jakub Köry (17980273)

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

Subjects:

Inducible expression of GlmR results in dose-dependent increases in ceftriaxone resistance. by Dušanka Djorić (16649064)

Data_Sheet_1_Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity... by Jia Wang (51945)

Table_1_Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models.xlsx by Meike Kaehler (4561306)

“…</p>Results<p>In this model, acquired sequence variants in NRAS, KRAS, PTPN11, and PDGFRB were identified in TKI resistance. The well-known pathogenic NRAS p.(Gln61Lys) variant provided a strong benefit for CML cells under TKI exposure visible by increased cell number (6.2-fold, p < 0.001) and decreased apoptosis (-25%, p < 0.001), proving the functionality of our approach. …”

Image_1_CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.tif by Bowen Li (200859)

Image_3_CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.tif by Bowen Li (200859)

Image_2_CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.tif by Bowen Li (200859)

Image_2_WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.TIF by Lian Gong (8594868)

Image_1_WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.TIF by Lian Gong (8594868)